Parichehr Pasbakhsh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Parichehr Pasbakhsh has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Iraj Ragerdi Kashani
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
6 shared publications - Davood Zarini
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications - Reza Asadi-Golshan
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications - Maedeh Hashemi
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Shiva Amirizadeh
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications - Maryam Shabani
Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Wiley in Animal Models and Experimental Medicine
Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination
Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). Changes in the microenvironment surrounding oligodendrocyte progenitor cells (OPCs), characterized by excessive production of extracellular matrix (ECM) components driven by elevated TGF‐β and CTGF signaling, impair the remyelination capacity of these cells. Decorin (DCN), an endogenous inhibitor of the TGF‐β/CTGF signaling axis, has emerged as a potential regulator of ECM homeostasis. Methods: To improve the therapeutic outcomes of stem cell‐based strategies, adipose‐derived mesenchymal stem cells (ADMSCs) were preconditioned with metformin (MET) before transplantation into a C57BL/6 mouse model of cuprizone‐induced demyelination. Cell viability and the expression of CXCR4 and SDF‐1α were evaluated to determine the migratory potential following MET preconditioning. Remyelination and oligodendroglial lineage dynamics were assessed using Luxol Fast Blue (LFB) staining and analysis of MBP and NG2 expression. ECM remodeling and mechanosensitive signaling were evaluated through the expression of DCN, TGF‐β, CTGF, and Piezo 1. Results: MET preconditioning was optimized at 1 mmol/L for 24 h based on MTT assay results and increased the migratory potential of ADMSCs, as indicated by upregulation of the CXCR4/SDF‐1α axis. Histological analysis revealed enhanced remyelination, accompanied by increased MBP and reduced NG2 expression in treated groups. At the molecular level, transplantation of MET‐preconditioned ADMSCs upregulated DCN while downregulating TGF‐β, CTGF, and Piezo 1 expression. Conclusion: MET preconditioning enhances the therapeutic efficacy of ADMSCs through increasing migration and homing of these cells and consequently promotes remyelination in a cuprizone‐induced demyelination model, potentially through DCN‐mediated mechanisms.
- 16 November 2026
- Published by Wiley in Animal Models and Experimental Medicine
Open AccessMetformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination
Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). Changes in the microenvironment surrounding oligodendrocyte progenitor cells (OPCs), characterized by excessive production of extracellular matrix (ECM) components driven by elevated TGF‐β and CTGF signaling, impair the remyelination capacity of these cells. Decorin (DCN), an endogenous inhibitor of the TGF‐β/CTGF signaling axis, has emerged as a potential regulator of ECM homeostasis. Methods: To improve the therapeutic outcomes of stem cell‐based strategies, adipose‐derived mesenchymal stem cells (ADMSCs) were preconditioned with metformin (MET) before transplantation into a C57BL/6 mouse model of cuprizone‐induced demyelination. Cell viability and the expression of CXCR4 and SDF‐1α were evaluated to determine the migratory potential following MET preconditioning. Remyelination and oligodendroglial lineage dynamics were assessed using Luxol Fast Blue (LFB) staining and analysis of MBP and NG2 expression. ECM remodeling and mechanosensitive signaling were evaluated through the expression of DCN, TGF‐β, CTGF, and Piezo 1. Results: MET preconditioning was optimized at 1 mmol/L for 24 h based on MTT assay results and increased the migratory potential of ADMSCs, as indicated by upregulation of the CXCR4/SDF‐1α axis. Histological analysis revealed enhanced remyelination, accompanied by increased MBP and reduced NG2 expression in treated groups. At the molecular level, transplantation of MET‐preconditioned ADMSCs upregulated DCN while downregulating TGF‐β, CTGF, and Piezo 1 expression. Conclusion: MET preconditioning enhances the therapeutic efficacy of ADMSCs through increasing migration and homing of these cells and consequently promotes remyelination in a cuprizone‐induced demyelination model, potentially through DCN‐mediated mechanisms.
- Open Access
- 18 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0343039
Effect of transplanted oligodendrocyte precursor cells derived from inflammatory and non-inflammatory microenvironment on remyelination in a chronic cuprizone model
Introduction: Multiple sclerosis is a chronic demyelinating disease of the central nervous system. Transplantation of oligodendrocyte progenitor cells (OPCs) is a promising approach to enhance remyelination; however, the influence of the OPCs’ microenvironmental origin on their therapeutic efficacy remains unclear. This study compared the remyelinating capacity of OPCs isolated from inflammatory (lipopolysaccharide) and non-inflammatory (cuprizone) microenvironments after transplanting into the corpus callosum and examined their effects on extracellular matrix chondroitin sulfate proteoglycans (CSPGs). Methods: OPCs were isolated from two microenvironments and characterized by immunocytochemistry and RT-qPCR. After transplanting, OPC homing, remyelination, gene expression, and CSPG levels were evaluated using DiI labeling, LFB staining, RT-qPCR, and immunofluorescence, respectively. Results: Severe demyelination exhibited in the cuprizone group compared with healthy controls (p < 0.001) by Luxol fast blue staining. Myelin content significantly increased in both transplating OPCs groups (p < 0.001), with a higher impact observed in mice received OPCs isolated from cuprizone as compared with lipopolysaccharide (p < 0.001). Also, RT-qPCR analysis exhibited significantly reduced MBP expression in the cuprizone group, whereas was significantly increased after OPC transplantation, particularly in the cuprizone-derived OPC group (p < 0.001), whereas a lower increased with lipopolysaccharide-derived OPCs (p < 0.01). MOG expression exhibited a same pattern, with a significantly increase in the cuprizone-derived OPC group compared with both the cuprizone and lipopolysaccharide-derived OPC groups (p < 0.001). Additionally, Immunofluorescence analysis exhibited increasing CSPG4 levels in the cuprizone group, but significantly reduced after OPC transplantation (p < 0.001). Notably, in the cuprizone-derived OPC group higher reduction of CSPG4 levels observed compare with in the lipopolysaccharide-derived OPC group (p < 0.001). Conclusion: OPC transplantation improves remyelination and reduces the CSPG level, but the effectiveness is more related to the previous history of the OPC isolation microenvironment and the new donor.
- 18 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0343039
Open AccessEffect of transplanted oligodendrocyte precursor cells derived from inflammatory and non-inflammatory microenvironment on remyelination in a chronic cuprizone model
Introduction: Multiple sclerosis is a chronic demyelinating disease of the central nervous system. Transplantation of oligodendrocyte progenitor cells (OPCs) is a promising approach to enhance remyelination; however, the influence of the OPCs’ microenvironmental origin on their therapeutic efficacy remains unclear. This study compared the remyelinating capacity of OPCs isolated from inflammatory (lipopolysaccharide) and non-inflammatory (cuprizone) microenvironments after transplanting into the corpus callosum and examined their effects on extracellular matrix chondroitin sulfate proteoglycans (CSPGs). Methods: OPCs were isolated from two microenvironments and characterized by immunocytochemistry and RT-qPCR. After transplanting, OPC homing, remyelination, gene expression, and CSPG levels were evaluated using DiI labeling, LFB staining, RT-qPCR, and immunofluorescence, respectively. Results: Severe demyelination exhibited in the cuprizone group compared with healthy controls (p < 0.001) by Luxol fast blue staining. Myelin content significantly increased in both transplating OPCs groups (p < 0.001), with a higher impact observed in mice received OPCs isolated from cuprizone as compared with lipopolysaccharide (p < 0.001). Also, RT-qPCR analysis exhibited significantly reduced MBP expression in the cuprizone group, whereas was significantly increased after OPC transplantation, particularly in the cuprizone-derived OPC group (p < 0.001), whereas a lower increased with lipopolysaccharide-derived OPCs (p < 0.01). MOG expression exhibited a same pattern, with a significantly increase in the cuprizone-derived OPC group compared with both the cuprizone and lipopolysaccharide-derived OPC groups (p < 0.001). Additionally, Immunofluorescence analysis exhibited increasing CSPG4 levels in the cuprizone group, but significantly reduced after OPC transplantation (p < 0.001). Notably, in the cuprizone-derived OPC group higher reduction of CSPG4 levels observed compare with in the lipopolysaccharide-derived OPC group (p < 0.001). Conclusion: OPC transplantation improves remyelination and reduces the CSPG level, but the effectiveness is more related to the previous history of the OPC isolation microenvironment and the new donor.
- 6 February 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (3) , 235
Bone marrow mesenchymal stem cells ameliorate intermittent multiple sclerosis: quantitative cerebellar microscopy and functional analysis in cuprizone-induced mice
Background Multiple sclerosis (MS) results in histological alterations, which in turn leads to behavioral deficits. Bone marrow mesenchymal stem cells (BMSCs) demonstrate therapeutic potential in MS. This study aimed to assess whether intranasally delivered BMSCs improve cerebellar structure and motor function in an intermittent cuprizone-induced (INT-CPZ) MS model. Methods The mice were divided into five groups: control, CPZ, CPZ + BMSC, INT-CPZ, and INT-CPZ + BMSC. BMSCs were intranasally delivered at weeks 4 and 10. Motor performance was evaluated using beam walking, pole, and ladder rung walking tests. Stereological analyses were performed to estimate cortex and white matter volumes and Purkinje cell number. Results BMSC treatment improved motor coordination and balance, particularly in INT-CPZ + BMSC mice, which outperformed the CPZ + BMSC group. Stereological results showed reduced volume loss in cortex and white matter and higher Purkinje cell number in BMSC-treated groups, with INT-CPZ + BMSC showing the most pronounced effect. Conclusion Intranasal BMSC therapy effectively preserved cerebellar structure and motor function in cuprizone-exposed mice. Intermittent cuprizone exposure enhanced BMSC efficacy, likely through mechanisms involving neuroregeneration, and neuroprotection.
- 6 February 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (3) , 235
Bone marrow mesenchymal stem cells ameliorate intermittent multiple sclerosis: quantitative cerebellar microscopy and functional analysis in cuprizone-induced mice
Background Multiple sclerosis (MS) results in histological alterations, which in turn leads to behavioral deficits. Bone marrow mesenchymal stem cells (BMSCs) demonstrate therapeutic potential in MS. This study aimed to assess whether intranasally delivered BMSCs improve cerebellar structure and motor function in an intermittent cuprizone-induced (INT-CPZ) MS model. Methods The mice were divided into five groups: control, CPZ, CPZ + BMSC, INT-CPZ, and INT-CPZ + BMSC. BMSCs were intranasally delivered at weeks 4 and 10. Motor performance was evaluated using beam walking, pole, and ladder rung walking tests. Stereological analyses were performed to estimate cortex and white matter volumes and Purkinje cell number. Results BMSC treatment improved motor coordination and balance, particularly in INT-CPZ + BMSC mice, which outperformed the CPZ + BMSC group. Stereological results showed reduced volume loss in cortex and white matter and higher Purkinje cell number in BMSC-treated groups, with INT-CPZ + BMSC showing the most pronounced effect. Conclusion Intranasal BMSC therapy effectively preserved cerebellar structure and motor function in cuprizone-exposed mice. Intermittent cuprizone exposure enhanced BMSC efficacy, likely through mechanisms involving neuroregeneration, and neuroprotection.
- 10 July 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (9) , 2220-2232
Impact of Sleep Deprivation on Bone Marrow Mesenchymal Stem Cell-Mediated Remyelination in the Corpus Callosum of Male Mice
- 10 July 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (9) , 2220-2232
Impact of Sleep Deprivation on Bone Marrow Mesenchymal Stem Cell-Mediated Remyelination in the Corpus Callosum of Male Mice
- 5 July 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (4) , 1-14
Impaired therapeutic efficacy of sleep-deprived bone marrow mesenchymal stem cells in the cerebellum of mouse cuprizone model of multiple sclerosis: stereological and motor behavioral evidence
Multiple sclerosis (MS) leads to histological changes, which in turn result in functional deficits. Studies have reported that bone marrow mesenchymal stem cells (BMSCs) have therapeutic benefits in MS. In addition, sleep deprivation affects therapeutic potential of BMSCs. This research aimed to evaluate the effects of BMSCs compared to sleep-deprived BMSCs (SD-BMSCs) on the motor behavior and histological recovery in MS. The mice were divided into four groups receiving cuprizone for five weeks, with or without intranasal administration of cells (BMSCs or SD-BMSCs) after five weeks. After a two-week recovery period, balance beam and pole tests were performed to assess motor performance, followed by estimation of histological parameters using stereological methods. Mice that received BMSCs scored significantly better than the SD-BMSC group in balance beam and pole tests (P < 0.05). The total cerebellar volume, cortex, and white matter volumes, as well as the total number of Purkinje cells in mice that received BMSCs, were significantly higher compared to those in the SD-BMSC group (P < 0.05). Intranasal administration of BMSCs leads to significantly improved motor behavior and histological regeneration of the cerebellum, including cortex and white matter as well as Purkinje cells compared to SD-BMSCs in a cuprizone model of multiple sclerosis.
- 5 July 2025
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 56 (4) , 1-14
Impaired therapeutic efficacy of sleep-deprived bone marrow mesenchymal stem cells in the cerebellum of mouse cuprizone model of multiple sclerosis: stereological and motor behavioral evidence
Multiple sclerosis (MS) leads to histological changes, which in turn result in functional deficits. Studies have reported that bone marrow mesenchymal stem cells (BMSCs) have therapeutic benefits in MS. In addition, sleep deprivation affects therapeutic potential of BMSCs. This research aimed to evaluate the effects of BMSCs compared to sleep-deprived BMSCs (SD-BMSCs) on the motor behavior and histological recovery in MS. The mice were divided into four groups receiving cuprizone for five weeks, with or without intranasal administration of cells (BMSCs or SD-BMSCs) after five weeks. After a two-week recovery period, balance beam and pole tests were performed to assess motor performance, followed by estimation of histological parameters using stereological methods. Mice that received BMSCs scored significantly better than the SD-BMSC group in balance beam and pole tests (P < 0.05). The total cerebellar volume, cortex, and white matter volumes, as well as the total number of Purkinje cells in mice that received BMSCs, were significantly higher compared to those in the SD-BMSC group (P < 0.05). Intranasal administration of BMSCs leads to significantly improved motor behavior and histological regeneration of the cerebellum, including cortex and white matter as well as Purkinje cells compared to SD-BMSCs in a cuprizone model of multiple sclerosis.
- 24 February 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-11
Benefits of bone marrow mesenchymal stem cells compared to their conditioned medium in valproic acid-induced autism in rats
Background Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by repetitive behaviors, a limited range of activities, and deficiencies in social communications. Bone marrow mesenchymal stem cells (BM-MSCs), which secrete factors that stimulate surrounding microenvironment, and BM-MSCs conditioned medium (BM-MSCs-CM), which contains cell-secreted products, have been speculated to hold potential as a therapy for ASD. This study aimed to compare the therapeutic effects of BM-MSCs and BM-MSCs-CM on behavioral and microglial changes in an animal model of autism induced by valproic acid (VPA). Methods and results Pregnant Wistar rats were administered by VPA at a dose of 600 mg/kg at 12.5 days post-conception. After birth, male pups were included in the study. At 6 weeks of age, one group of rats received intranasal administration of BM-MSCs, while another group received BM-MSCs-CM. The rats were allowed to recover for 2 weeks. Behavioral tests, quantitative real-time polymerase chain reaction (qRT-PCR), and immunohistochemistry were performed. Both BM-MSCs and BM-MSCs-CM administration significantly improved some behavioral deficits. Furthermore, these treatments notably reduced Iba-1 marker associated with microgliosis. Additionally, there was a significant reduction in the expression of pro-inflammatory cytokines IL-1β and IL-6, and an increase in the levels of the anti-inflammatory cytokine IL-10 in rats administered by BM-MSCs and BM-MSCs-CM. Conclusions Post-developmental administration of BM-MSCs and BM-MSCs-CM can ameliorate prenatal neurodevelopmental deficits, restore cognitive and social behaviors, and modulate microglial and inflammatory markers. Results indicated that the improvement rate was higher in the BM-MSCs group than BM-MSCs-CM group.
- 24 February 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-11
Benefits of bone marrow mesenchymal stem cells compared to their conditioned medium in valproic acid-induced autism in rats
Background Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by repetitive behaviors, a limited range of activities, and deficiencies in social communications. Bone marrow mesenchymal stem cells (BM-MSCs), which secrete factors that stimulate surrounding microenvironment, and BM-MSCs conditioned medium (BM-MSCs-CM), which contains cell-secreted products, have been speculated to hold potential as a therapy for ASD. This study aimed to compare the therapeutic effects of BM-MSCs and BM-MSCs-CM on behavioral and microglial changes in an animal model of autism induced by valproic acid (VPA). Methods and results Pregnant Wistar rats were administered by VPA at a dose of 600 mg/kg at 12.5 days post-conception. After birth, male pups were included in the study. At 6 weeks of age, one group of rats received intranasal administration of BM-MSCs, while another group received BM-MSCs-CM. The rats were allowed to recover for 2 weeks. Behavioral tests, quantitative real-time polymerase chain reaction (qRT-PCR), and immunohistochemistry were performed. Both BM-MSCs and BM-MSCs-CM administration significantly improved some behavioral deficits. Furthermore, these treatments notably reduced Iba-1 marker associated with microgliosis. Additionally, there was a significant reduction in the expression of pro-inflammatory cytokines IL-1β and IL-6, and an increase in the levels of the anti-inflammatory cytokine IL-10 in rats administered by BM-MSCs and BM-MSCs-CM. Conclusions Post-developmental administration of BM-MSCs and BM-MSCs-CM can ameliorate prenatal neurodevelopmental deficits, restore cognitive and social behaviors, and modulate microglial and inflammatory markers. Results indicated that the improvement rate was higher in the BM-MSCs group than BM-MSCs-CM group.
- Open Access
- 29 October 2021
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 16 (1) , 1-4
A potential misdiagnosis in the COVID-19 pandemic era: a case report of superimposed thrombosis or tumor recurrence
Background: The clinical manifestations of coronavirus disease 2019 (COVID-19) overlap with those of other disorders, especially cardiovascular disease. Case presentation: We herein describe a 58-year-old woman who presented with syncopal episodes and dyspnea on exertion with a left atrial (LA) mass, scheduled for surgical removal and mitral valve replacement. Nearly 3 months later, the patient developed dyspnea, fever, and a sore throat, resulting in hospital admission with suspected COVID-19. During the diagnostic evaluation, a larger LA mass was detected. The mass seemed to be a COVID-19–induced organized thrombus with prosthetic mitral valve malfunction. Resection was, therefore, planned. An immunohistochemistry study revealed a liposarcoma. Conclusions: The unusual early recurrence of liposarcomas and the misdiagnosis with COVID-19–induced thrombosis are the hallmark of the present case.
- 29 October 2021
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 16 (1) , 1-4
Open AccessA potential misdiagnosis in the COVID-19 pandemic era: a case report of superimposed thrombosis or tumor recurrence
Background: The clinical manifestations of coronavirus disease 2019 (COVID-19) overlap with those of other disorders, especially cardiovascular disease. Case presentation: We herein describe a 58-year-old woman who presented with syncopal episodes and dyspnea on exertion with a left atrial (LA) mass, scheduled for surgical removal and mitral valve replacement. Nearly 3 months later, the patient developed dyspnea, fever, and a sore throat, resulting in hospital admission with suspected COVID-19. During the diagnostic evaluation, a larger LA mass was detected. The mass seemed to be a COVID-19–induced organized thrombus with prosthetic mitral valve malfunction. Resection was, therefore, planned. An immunohistochemistry study revealed a liposarcoma. Conclusions: The unusual early recurrence of liposarcomas and the misdiagnosis with COVID-19–induced thrombosis are the hallmark of the present case.
- 1 October 2021
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 116, 102013
Protective Features of Calorie Restriction on Cuprizone-induced Demyelination via Modulating Microglial Phenotype
- 1 October 2021
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 116, 102013
Protective Features of Calorie Restriction on Cuprizone-induced Demyelination via Modulating Microglial Phenotype